In our small cohort, high levels of plasma NfL were associated with shorter survival in people with PSP, aligning with similar findings in larger cohorts.6,34 Conversely, GFAP levels were not significantly associated with survival in people with PSP (Supplementary Table 6). This evidence concerns the gene GFAP and supranuclear palsy, progressive, 1.